Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
George D. Demetri, Patrick Schöffski, Giovanni Grignani, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 30, pp. 3433-3439
Closed Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, et al.
Annals of Oncology (2018) Vol. 29, pp. iv51-iv67
Open Access | Times Cited: 1504
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, et al.
Annals of Oncology (2021) Vol. 32, Iss. 11, pp. 1348-1365
Open Access | Times Cited: 664
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams, Dingcheng Gao, Andrew Redfern, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 716-732
Open Access | Times Cited: 373
Clinical and Molecular Spectrum of Liposarcoma
Alex Thomas John Lee, Khin Thway, Paul H. Huang, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 2, pp. 151-159
Open Access | Times Cited: 284
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
Naotaka Hayasaka, Kohichi Takada, Hajime Nakamura, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 156
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas
Mrinal M. Gounder, Todd M. Bauer, Gary K. Schwartz, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 9, pp. 1714-1724
Open Access | Times Cited: 49
Enriching cancer pharmacology with drugs of marine origin
Paula C. Jimenez, Diego Veras Wilke, Paola Cristina Branco, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 1, pp. 3-27
Open Access | Times Cited: 115
Drug review: Pazopanib
Shingo Miyamoto, Shigenori Kakutani, Yujiro Sato, et al.
Japanese Journal of Clinical Oncology (2018) Vol. 48, Iss. 6, pp. 503-513
Open Access | Times Cited: 99
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
Candace L. Haddox, Michael J. Nathenson, Emanuele Mazzola, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 7, pp. 1281-1292
Open Access | Times Cited: 13
The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study
Chou‐Yi Hsu, Sarah Alwan Malik Al-Yasiri, A.H. Shather, et al.
Pramana (2024) Vol. 98, Iss. 2
Closed Access | Times Cited: 8
Dacarbazine nanoparticle topical delivery system for the treatment of melanoma
Abdul Hafeez, Imran Kazmi
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
Javier Cortés, Patrick Schöffski, Bruce A. Littlefield
Cancer Treatment Reviews (2018) Vol. 70, pp. 190-198
Open Access | Times Cited: 68
Dedifferentiated Liposarcoma: Systemic Therapy Options
Zhubin Gahvari, Amanda Parkes
Current Treatment Options in Oncology (2020) Vol. 21, Iss. 2
Closed Access | Times Cited: 65
Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives
Jun Nishio, Shizuhide Nakayama, Kazuki Nabeshima, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3230-3230
Open Access | Times Cited: 51
Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
Myrofora Panagi, Pampina Pilavaki, Anastasia Constantinidou, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6106-6129
Open Access | Times Cited: 31
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Mrinal M. Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 22, pp. 2479-2490
Open Access | Times Cited: 29
Chemotherapeutic drugs for soft tissue sarcomas: a review
Zhichao Tian, Weitao Yao
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Therapeutic strategies targeting folate receptor α for ovarian cancer
Jia Mai, Limei Wu, Ling Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
Kenji Nakano, Shunji Takahashi
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 739-739
Open Access | Times Cited: 52
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
Andrew Redfern, Lisa Spalding, Erik W. Thompson
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 285-308
Closed Access | Times Cited: 50
Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review
Richard F. Riedel, Robin L. Jones, Antoîne Italiano, et al.
Cancers (2018) Vol. 10, Iss. 11, pp. 417-417
Open Access | Times Cited: 48
Recent advances in the understanding and management of liposarcoma
Candace L. Haddox, Richard F. Riedel
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 35
Adsorption properties of dacarbazine with graphene/fullerene/metal nanocages – Reactivity, spectroscopic and SERS analysis
Jamelah S. Al‐Otaibi, Y. Sheena Mary, Y. Shyma Mary, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 268, pp. 120677-120677
Closed Access | Times Cited: 35
Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
Wei Xiong, Zhengdong Guo, Baoyan Zeng, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 23
Myxoid Liposarcomas: Systemic Treatment Options
Elise F. Nassif, Emily Z. Keung, Prapassorn Thirasastr, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 4, pp. 274-291
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top